Cancer Research and Treatment

Cancer Research and Treatment Search

> Browse Articles > Search

Gastrointestinal cancer

The Oncologic Implications of Tumor Multiplicity in Intrahepatic Cholangiocarcinoma: Its Prognostic Value Might Be Underestimated

So Jeong Yoon, Sunghae Park, Hongbeom Kim, Sang Hyun Shin, Jin Seok Heo, Jinsoo Rhu, Gyu-Seong Choi, Jong Man Kim, Jae-Won Joh, In Woong Han

Cancer Res Treat. 2023;55(3):948-955. Published online February 27, 2023 DOI: https://doi.org/10.4143/crt.2023.290

Effect of Combining EGFR Tyrosine Kinase Inhibitors and Cytotoxic Agents on Cholangiocarcinoma Cells

Boonyakorn Boonsri, Kiren Yacqub-Usman, Pakpoom Thintharua, Kyaw Zwar Myint, Thannicha Sae-Lao, Pam Collier, Chinnawut Suriyonplengsaeng, Noppadol Larbcharoensub, Brinda Balasubramanian, Simran Venkatraman, Isioma U. Egbuniwe, Dhanwant Gomez, Abhik Mukherjee, Supeecha Kumkate, Tavan Janvilisri, Abed M Zaitoun, Thiti Kuakpaetoon, Rutaiwan Tohtong, Anna M Grabowska, David O. Bates, Kanokpan Wongprasert

Cancer Res Treat. 2021;53(2):457-470. Published online October 7, 2020 DOI: https://doi.org/10.4143/crt.2020.585

Crossref 7

Long Non-coding RNA CASC15 Promotes Intrahepatic Cholangiocarcinoma Possibly through Inducing PRDX2/PI3K/AKT Axis

Yuan Zhang, Lufei Zhang, Sinan Lu, Yucheng Xiang, Cheng Zeng, Tianyu He, Yuan Ding, Weilin Wang

Cancer Res Treat. 2021;53(1):184-198. Published online October 5, 2020 DOI: https://doi.org/10.4143/crt.2020.192

Web of Science 13 Crossref 12

Prognostic Predictability of American Joint Committee on Cancer 8th Staging System for Perihilar Cholangiocarcinoma: Limited Improvement Compared with the 7th Staging System

Jong Woo Lee, Jae Hoon Lee, Yejong Park, Woohyung Lee, Jaewoo Kwon, Ki Byung Song, Dae Wook Hwang, Song Cheol Kim

Cancer Res Treat. 2020;52(3):886-895. Published online March 12, 2020 DOI: https://doi.org/10.4143/crt.2020.023

Web of Science 11 Crossref 7

Efficacy and Safety of Pembrolizumab in Patients with Refractory Advanced Biliary Tract Cancer: Tumor Proportion Score as a Potential Biomarker for Response

Junho Kang, Jae Ho Jeong, Hee-Sang Hwang, Sang Soo Lee, Do Hyun Park, Dong Wook Oh, Tae Jun Song, Ki-Hun Kim, Shin Hwang, Dae Wook Hwang, Song Cheol Kim, Jin-hong Park, Seung-Mo Hong, Kyu-pyo Kim, Baek-Yeol Ryoo, Changhoon Yoo

Cancer Res Treat. 2020;52(2):594-603. Published online December 18, 2019 DOI: https://doi.org/10.4143/crt.2019.493

Web of Science 47 Crossref 46

An Integrated Nomogram Combining Clinical Factors and Microtubule-Associated Protein 1 Light Chain 3B Expression to Predict Postoperative Prognosis in Patients with Intrahepatic Cholangiocarcinoma

Liang Chen, Hongyuan Fu, Tongyu Lu, Jianye Cai, Wei Liu, Jia Yao, Jinliang Liang, Hui Zhao, Jiebin Zhang, Jun Zheng, Yingcai Zhang, Yang Yang

Cancer Res Treat. 2020;52(2):469-480. Published online October 7, 2019 DOI: https://doi.org/10.4143/crt.2019.423

Web of Science 6 Crossref 6

Clinical Benefit of Maintenance Therapy for Advanced Biliary Tract Cancer Patients Showing No Progression after First-Line Gemcitabine Plus Cisplatin

Jaewon Hyung, Bumjun Kim, Changhoon Yoo, Kyo-pyo Kim, Jae Ho Jeong, Heung-Moon Chang, Baek-Yeol Ryoo

Cancer Res Treat. 2019;51(3):901-909. Published online October 4, 2018 DOI: https://doi.org/10.4143/crt.2018.326

Web of Science 15 Crossref 16

Validation of the Eighth American Joint Committee on Cancer Staging System for Distal Bile Duct Carcinoma

Sun-Young Jun, You-Na Sung, Jae Hoon Lee, Kwang-Min Park, Young-Joo Lee, Seung-Mo Hong

Cancer Res Treat. 2019;51(1):98-111. Published online March 2, 2018 DOI: https://doi.org/10.4143/crt.2017.595

Web of Science 20 Crossref 20

Multicenter Phase II Study of Oxaliplatin, Irinotecan, and S-1 as First-line Treatment for Patients with Recurrent or Metastatic Biliary Tract Cancer

Changhoon Yoo, Boram Han, Hyeong Su Kim, Kyu-pyo Kim, Deokhoon Kim, Jae Ho Jeong, Jae-Lyun Lee, Tae Won Kim, Jung Han Kim, Dae Ro Choi, Hong Il Ha, Jinwon Seo, Heung-Moon Chang, Baek-Yeol Ryoo, Dae Young Zang

Cancer Res Treat. 2018;50(4):1324-1330. Published online January 8, 2018 DOI: https://doi.org/10.4143/crt.2017.526

Web of Science 19 Crossref 19

Proximal Resection Margins: More Prognostic than Distal Resection Margins in Patients Undergoing Hilar Cholangiocarcinoma Resection

Tae Yoo, Sang-Jae Park, Sung-Sik Han, Seong Hoon Kim, Seung Duk Lee, Tae Hyun Kim, Soon-ae Lee, Sang Myung Woo, Woo Jin Lee, Eun Kyung Hong

Cancer Res Treat. 2018;50(4):1106-1113. Published online November 16, 2017 DOI: https://doi.org/10.4143/crt.2017.320

Web of Science 15 Crossref 10

Declined Preoperative Aspartate Aminotransferase to Neutrophil Ratio Index Predicts Poor Prognosis in Patients with Intrahepatic Cholangiocarcinoma after Hepatectomy

Lingyun Liu, Wei Wang, Yi Zhang, Jianting Long, Zhaohui Zhang, Qiao Li, Bin Chen, Shaoqiang Li, Yunpeng Hua, Shunli Shen, Baogang Peng

Cancer Res Treat. 2018;50(2):538-550. Published online June 1, 2017 DOI: https://doi.org/10.4143/crt.2017.106

Web of Science 15 Crossref 15

Long-Term Outcome of Distal Cholangiocarcinoma after Pancreaticoduodenectomy Followed by Adjuvant Chemoradiotherapy: A 15-Year Experience in a Single Institution

Byoung Hyuck Kim, Kyubo Kim, Eui Kyu Chie, Jeanny Kwon, Jin-Young Jang, Sun Whe Kim, Do-Youn Oh, Yung-Jue Bang

Cancer Res Treat. 2017;49(2):473-483. Published online August 23, 2016 DOI: https://doi.org/10.4143/crt.2016.166

Web of Science 21 Crossref 22

Rare Incidence of ROS1 Rearrangement in Cholangiocarcinoma

Sun Min Lim, Jeong Eun Yoo, Kiat Hon Lim, David Wai Meng Tai, Byoung Chul Cho, Young Nyun Park

Cancer Res Treat. 2017;49(1):185-192. Published online April 27, 2016 DOI: https://doi.org/10.4143/crt.2015.497

Web of Science 15 Crossref 14

Estimation of the Incidence of Hepatocellular Carcinoma and Cholangiocarcinoma in Songkhla, Thailand, 1989-2013, Using Multiple Imputation Method

Seesai Yeesoonsang, Surichai Bilheem, Edward McNeil, Sophon Iamsirithaworn, Chuleeporn Jiraphongsa, Hutcha Sriplung

Cancer Res Treat. 2017;49(1):54-60. Published online May 18, 2016 DOI: https://doi.org/10.4143/crt.2016.045

Web of Science 6 Crossref 5

Dermatomyositis in a Patient with Cholangiocarcinoma Detected by an [¹⁸F]-Fluorodeoxyglucose Positron Emission Tomography–Computed Tomography Scan

Koung Jin Suh, Jin Kyun Park, Seongcheol Cho, Hyunkyung Park, Hae Woon Baek, Kyoungbun Lee, Dong Soo Lee, Kyung-Hun Lee

Cancer Res Treat. 2016;48(2):848-852. Published online March 18, 2015 DOI: https://doi.org/10.4143/crt.2014.310

Web of Science 5 Crossref 7

Surgery Alone Versus Surgery Followed by Chemotherapy and Radiotherapy in Resected Extrahepatic Bile Duct Cancer: Treatment Outcome Analysis of 336 Patients

Jung Ho Im, Jinsil Seong, Ik Jae Lee, Joon Seong Park, Dong Sup Yoon, Kyung Sik Kim, Woo Jung Lee, Kyung Ran Park

Cancer Res Treat. 2016;48(2):583-595. Published online July 22, 2015 DOI: https://doi.org/10.4143/crt.2015.091

Web of Science 38 Crossref 34

Gemcitabine Plus Cisplatin for Advanced Biliary Tract Cancer: A Systematic Review

Joon Oh Park, Do-Youn Oh, Chiun Hsu, Jen-Shi Chen, Li-Tzong Chen, Mauro Orlando, Jong Seok Kim, Ho Yeong Lim

Cancer Res Treat. 2015;47(3):343-361. Published online May 18, 2015 DOI: https://doi.org/10.4143/crt.2014.308

Web of Science 68 Crossref 64

Two Cases of Humoral Hypercalcemia of Malignancy in Metastatic Cholangiocarcinoma

Seungtaek Lim, Jungwoo Han, Kyeong Hye Park, Won Jai Jung, Yong Kang Lee, Ara Choi, Young Jae Kim, Jong-Chan Lee, Hye Jin Choi

Cancer Res Treat. 2013;45(2):145-149. Published online June 30, 2013 DOI: https://doi.org/10.4143/crt.2013.45.2.145

Crossref 7

A Case of Combined Hepatocellular-Cholangiocarcinoma with Favorable Response to Systemic Chemotherapy

Gun Min Kim, Hei-Cheul Jeung, Dokyung Kim, Joo Hoon Kim, Sang Hyun Yoon, Eun Suk Jung, Sang Joon Shin

Cancer Res Treat. 2010;42(4):235-238. Published online December 31, 2010 DOI: https://doi.org/10.4143/crt.2010.42.4.235

Crossref 14

Severe Hypothyroidism Induced by Thyroid Metastasis of Cholangiocarcinoma

Woo Kyun Bae, Hyun Jeong Shim, Yoo Duk Choi, Jin Woong Kim, Sang Hee Cho, Ho Cheol Kang, Ik Joo Chung

Cancer Res Treat. 2009;41(1):56-58. Published online March 31, 2009 DOI: https://doi.org/10.4143/crt.2009.41.1.56

Crossref 9

Immunohistochemical Study for CD44v6 in Hepatocellular Carcinoma and Cholangiocarcinoma

Ki Jung Yun, Kwon Ha Yoon, Weon Cheol Han

Cancer Res Treat. 2002;34(3):170-174. Published online June 30, 2002 DOI: https://doi.org/10.4143/crt.2002.34.3.170

Crossref 4

Immunohistochemical Study of beta-catenin Expression between Hepatocellular Carcinoma and Cholangiocarcinoma

Ki Jung Yun, Weon Cheol Han, Suck Chei Choi, Tae Hyeon Kim

Cancer Res Treat. 2002;34(2):117-121. Published online April 30, 2002 DOI: https://doi.org/10.4143/crt.2002.34.2.117

Crossref 7

Multiple Primary Cancers in the Stomach and Different Organs

Byung Moo Jeon, Nam Il Kim, Jung Soo Kim, Hae Myung Jeon, Seung Jin Yoo, Jae Sung Kim, Sung Hoon Kim, Eun Jung Lee

J Korean Cancer Assoc. 1996;28(2):394-404.

Combined High Dose Radiotherapy with Sequential Gemcitabine-Cisplatin Based Chemotherapy Increase the Resectability and Survival in Locally Advanced Unresectable Intrahepatic Cholangiocarcinoma: A Multi-Institutional Cohort Study

Jung Ho Im, Jeong Il Yu, Tae Hyun Kim, Tae Gyu Kim, Jun Won Kim, Jinsil Seong

Received July 28, 2023 Accepted December 31, 2023 Published online January 2, 2024
DOI: https://doi.org/10.4143/crt.2023.886
[Accepted]

Global Expanded Access Program for Pemigatinib in Patients with Previously Treated Locally Advanced or Metastatic Cholangiocarcinoma and Fibroblast Growth Factor Receptor Gene Alterations

Anouk Lindley, Gerald Prager, Michael Bitzer, Timothy C. Burn, Christine F. Lihou, Elisabeth Croft

Received November 8, 2023 Accepted February 6, 2024 Published online February 7, 2024
DOI: https://doi.org/10.4143/crt.2023.1197
[Accepted]